2026 Technical Sessions

Back to Suppliers’ Day 2026

Suppliers’ Day Technical Seminars

Nutrition & Product Design for a Market Shaped by UltraProcessed Foods and GLP1 Trends

Join us for “Nutrition & Product Design for a Market Shaped by Ultra Processed Foods and GLP 1 Trends,” a cutting edge technical seminar exploring the future of food innovation.

Discover the latest market and consumer insights, dive into emerging nutrition science, and gain practical product development and technical strategies to stay ahead in a rapidly shifting landscape.

Featuring expert speakers from Mondelez,  Nestlé Nutrition, Ingredion, Beneo, EGGLRock Nutrition and other experts listed below.  This session brings together top industry perspectives.

9:00am
– 9:10am
Welcome & Introduction

Welcome from Margaux​.

Margaux to review NY IFT Highlights and Upcoming Events and Introduce Marc.​

Marc to Introduce the 2026 IFT Suppliers Event – Technical Program

Presented by

Marc Meyers Managing Principal Meyers Consulting LLC
Margaux Mora NY IFT Chair & Sr. Associate – Global Sensory Ingredion
9:10am
– 9:35am
Exploring Consumer Needs and Wants
Through GLP-1 and Ultra-Processed Foods​

While GLP-1 medications are widely used to treat metabolic disease, achieving true metabolic homeostasis requires collaboration with the food industry to redesign ultra-processed food that enables low-volume eating, while meeting essential protein and fiber needs, supported by real patient outcomes.

Read the Abstract

Approximately 6% of U.S. adults—or over 15 million people—are currently taking GLP-1 drugs like Ozempic or Wegovy. Data from 2025 indicates that about 1 in 8 Americans (12%) have used these medications at some point for weight loss, diabetes, or heart disease management. As a Registered Dietitian (RDN) in private practice about 30% to 50% of my patients on any given week are using GLP-1s, either for the treatment of diabetes and/or weight loss (whether they are obese or not).

You can use the most effective drugs in the world to treat metabolic diseases, but you will not achieve homeostasis unless your nutrient needs are met. For decades (if not centuries) the food industry has done a remarkable job to meet those demands. The evolution of Ultra-Processed Foods (UPFs) was paved with good intentions as it helped to solve the food insecurity conundrum. In effort to enhance palatability though, nutrient density has been sacrificed. This is turn has contributed in large part to the obesity, diabetes and heart disease levels we see today. I sincerely believe that with the right modifications, we will be able to rely on UPFs (or a variation thereof) once again, to improve food access and simultaneously eliminate the undernutrition and overnutrition that has disrupted human metabolism.

GLP-1s will not achieve their goal without the collaboration of the food industry to ensure that they will work as advertised. This means low volume eating while meeting protein and fiber daily allowances. Healthcare providers (that’s me) will attest this is easier said than done and I will show you why. This brief presentation will illustrate actual changes in body composition and bloodwork from real patients that may serve as a blueprint for food product developers to meet the nutritional needs of a growing population of GLP-1 users.

Presented by

Laura Rokosz, PhD., RDN EGGLRock Nutrition LLC
Bio

Laura Rokosz is a Registered Dietitian Nutritionist (RDN) with 28 years of experience in the Pharmaceutical and Biotechnology industries. She received her B.S., M.S., and Ph.D in Food Science from Rutgers University and completed her RDN internship in the Rutgers Individual Supervised Practice Pathway (ISPP) Dietetics program. Dr. Rokosz was employed with Schering-Plough, Merck and Pharmacopeia where she supported R & D efforts in drug development. She is the author of over 40 peer-reviewed journal articles including five Expert Opinion articles on Obesity and Cancer.  A number of her blogs on fitness and nutrition have been published on various syndicated websites and in online periodicals. Dr. Rokosz is currently the owner of EGGLROCK Nutrition, LLC, an Integrative Healthcare practice providing dietary and lifestyle guidance for disease prevention and health maintenance.  EGGLRock Nutrition is a well-recognized community practice serving the health needs of both adults and children. Dr. Rokosz serves as an adjunct faculty member at Rutgers University and teaches group fitness classes at the Gateway Family YMCA of Union County, NJ. Be sure to tune into her podcast, “Eat Right with Laura” which can be found on her website at www.egglrock.com.

10:00am
– 10:25am
Nutrition & Lifestyle
in Weight Loss and Management

An overview of the burden of obesity and the new hope of GLP-1 medications, the potential downsides, nutrition and lifestyle recommendations. Change of behavior of GLP-1 users and why support & education are keys to success.

Presented by

David Despain Sr. Manager, R&D Platform – Weight Management Nutrition Nestle
Bio

At Nestlé Health Science, David Despain serves as a Senior R&D Manager for the Weight Management Nutrition Platform, where he leads innovation pipeline activities that advance the product innovation for consumers on GLP-1 therapy for obesity and type 2 diabetes. David holds dual master’s degrees—one in human nutrition from the University of Bridgeport and another in science communication from Stony Brook University. He is also an IFT-certified food scientist, a credential earned after more than a decade of research and development experience in the food industry.

10:40am
– 11:05am
Rethinking Food Formulation
for Satiety and Nutrient Density in the GLP-1 Era

Explore how to build robust nutrient-dense foods that deliver satiety, meet elevated customer expectations and support modern weight management goals.

Read the Abstract

The rise of GLP-1 medications is having a significant impact on consumer eating behavior. Food industry experts say it’s no longer just about counting calories—it’s about calories that count. For product developers, this isn’t about competing with a prescription. It’s about creating foods that earn their place on the plate. This session will explore how to build nutrient-dense foods that deliver satiety, meet elevated consumer expectations, and support modern weight-management goals.

Presented by

Nayara Jordan Customer Technical Support Manager Beneo
Bio

Nayara is a Certified Food Scientist with a diverse background in food science, product development, and technical support. With a foundation of training in commercial pastry and culinary arts, Nayara went on to study Food Science at Cornell University where she received her bachelor’s degree. She has seven years of experience in product development for the consumer packaged goods industry. Currently, she works at BENEO, Inc. a global ingredient manufacturer with a focus on supplying functional, plant-based, nutrition-forward ingredients. There, she leads technical support efforts for Mexico and the Northern US, providing solutions and inspiration through recipe development, presentations and technical problem-solving.

10:00am
– 10:25am
From Appetite Supression to System Transformation
Examining the GLP-1 Economy

This presentation examines how GLP-1s are reshaping not only appetite and weight, but also consumer behavior, food demand, wellness habits, and the broader “GLP-1 economy.”

Read the Abstract

GLP-1 therapies are doing far more than reducing appetite or supporting weight loss—they are beginning to reshape the broader systems that surround health, consumption, and daily life. This presentation examines the emergence of the “GLP-1 economy,” tracing how these medicines sit at the intersection of a growing obesity epidemic, a simple but powerful biologic mechanism, and measurable downstream effects on behavior and markets. From shifts in mindset, confidence, and lifestyle priorities to changing patterns in grocery purchasing, fitness, travel, and social behavior, GLP-1 adoption is creating ripple effects well beyond the clinic. By connecting the science of the mechanism to cultural and commercial transformation, this session will explore how GLP-1s may become not just a therapeutic advance, but a force that redefines how individuals live, how industries respond, and how society understands obesity itself.

Presented by

Dr. Suketu Patel, MD Global Chief Medical Officer Havas Health Network
Bio

Dr. Suketu Patel, MD, PhD, Global Chief Medical Officer at Havas Health Network.  He helps lead the GLP-1 consultancy under Havas Health (HH).  Suketu has more than 15 years of experience as a global medical director, launching and revitalizing brands, and working across a range of therapeutic areas including nutrition, immunology, oncology, neurology, genetics, and rare disease. He focuses on elevating the role of medical initiatives across the global network. HH seeks to better connect with institutions and leverage advanced data to drive effective communications in the modern marketplace.  He works with colleagues at Havas across North and South America, Europe and Asia. He has partnered closely with brands from small biotech to large pharma. Via the GLP-1 consultancy, Suketu and HH demonstrate that they are unafraid to be the company that steps first into this dynamic space.

10:25am
– 10:40am
Mid-Morning Break

11:05am
– 11:30am
Designing Snacks for the Evolving Consumer​

The US Food Industry is experiencing transformation : Changing government policies, expanding GLP-1 use, and an increasing focus on sugar. Product developers must adapt recipes and innovation approaches to changing consumers​.

Read the Abstract

The US food landscape is experiencing significant transformation.  This is driven by a convergence of factors including changing government policies and actions at both federal and state levels, the expanding use of GLP-1 medications for diabetes and weight loss, increasing focus on sugar, and retailers defining ingredient changes for their products. These changes are informing consumer attitudes and expectations regarding food ingredients and nutrition.  For product developers, this dynamic environment necessitates adapting core portfolio recipes and strategically shifting innovation approaches to design products for rapidly changing consumer needs and preferences

Presented by

Janice Bryson VP of R&D: Biscuits & Baked Snacks Mondelez
Bio

Janice Bryson is Vice President of R&D at Mondelez International, leading a global team focused on platform development and innovation for the Biscuits & Baked Snacks category. With 30+ years in the food industry, including roles at Nabisco and Kraft, her experience spans product innovation, ingredients technology, sustainability initiatives, and digital evolution.  Janice is passionate about translating consumer insights and technology advancements into innovative products that deliver exceptional experiences for evolving consumer preferences and fuel business growth.  She has the privilege of working on iconic snacking brands such as Oreo, Chips Ahoy!, Ritz, Trident, Halls, and Planters.  Janice holds a Bachelor’s and Master’s degree in Food Science from Rutgers University.

11:30am
– 11:55am
Appetite for Reduction
Growing your Business in a GLP-1 Future with Lower Volumes and Higher Values

Food formulations prioritizing energy density, trending micronutrients and altered taste profiles.

Read the Abstract

The food industry is navigating an unprecedented structural shift driven by the widespread adoption of GLP-1 medications and intensifying scrutiny of Ultra-Processed Foods (UPFs). As overall consumption volumes structurally decrease, the best nutritional science dictates a departure from a model of creating foods designed around hyper-palatability and “empty” calories. Instead, formulators must prioritize energy density, trending macronutrients, and altered taste profiles to win the future. As GLP-1 receptor agonists broaden their potential therapeutic range, these trends are poised to accelerate. While this poses significant challenges, the industry can leverage this moment as a mandate to transition toward purposeful, high-value product design. Antithesis Foods is executing this transition within the private-label sector, serving as a B2B engine to upgrade legacy snacks and supply category-leading, better-for-you nutritional platforms delivered as finished goods. We will discuss what we are hearing from our retail partners, manufacturing partners, and consumers, alongside our plans for future innovation.

Presented by

Jason Goodman Co-Founder & CEO Antithesis Foods​
Bio

Jason Goodman is the Co-Founder and CEO of Antithesis Foods. With a background in microbiology, biochemistry, and immunology, he began his career in R&D at pharmaceutical companies before pursuing a PhD in Food Science at Cornell University. His academic research investigated the intersection of taste biology, obesity, and the microbiome.

At Antithesis, he leads a team that leverages research on what makes processed food good or bad for human health to fix the food system. Antithesis reformulates classic processed foods to improve the food environment, creating high-protein, high-fiber products with lower energy density and great taste. Antithesis works exclusively with private label brands to get better-for-you food to more people, more affordably.

11:55am
– 12:25pm
Lunch

12:25pm
– 12:50pm
Improving Metabolic Benefits of Ultra-Processed Foods
Resistant Starch Research

Potential for naturally occurring Resistant Starch to improve the metabolic impact of processed foods​.

Read the Abstract

The health impact of starches and products of starch processing has been recently questioned as the rise of processed foods may correlate with increases in metabolic diseases such as type 2 diabetes, heart disease and obesity. Resistant starch (starch that resists digestion in the small intestine and reaches the large intestine) was abundant in unprocessed foods, but it is largely missing in today’s ultra-processed foods. When naturally occurring, resistant starch is added back into the diet, numerous clinical studies report important metabolic health benefits, generated through its prebiotic effects, the gut microbiota metabolites produced and their nutrigenomic impact on key metabolic pathways. This presentation will present some of the published evidence and suggest a marketing strategy for commercializing new products focusing on improving metabolic health.

Presented by

Rhonda Witwer Executive Director ResistantStarchResearch.com
Bio

Rhonda Scott Witwer has been marketing ingredients in the food industry for more than two decades and has written numerous articles and expert market reports on health-promoting ingredients.  She is an expert on resistant starch and is Executive Director of www.ResistantStarchResearch.com, which explains the scientific studies supporting resistant starch’s prebiotic health benefits. She worked with the Global Prebiotic Association to update the definition of “prebiotic” and propose a new definition for “prebiotic effect”, which was published in Advances in Nutrition in 2024. During Ms Witwer’s career, she has worked for numerous companies, including Ingredion, International Agriculture Group (IAG), Beneo, Monsanto, ADM and the Functional Foods for Health Program at the University of Illinois, most of which manufactured prebiotic, fermentable dietary fibers and other bioactive ingredients. She managed NuBana® green banana flour business for IAG and managed Hi-maize® resistant starch for Ingredion.

She has been responsible for building recognition for resistant starch’s health benefits as a prebiotic fiber for gut health, blood sugar health, and a healthy metabolism. She has translated more than 400 published studies supporting resistant starch into understandable, credible marketing messages now being used all over the world. She was also instrumental in securing the qualified health claim that resistant starch reduces the risk of type 2 diabetes, approved by the U.S. Food & Drug Administration (FDA) in December 2016. A graduate of Butler University with a B.S. in Chemistry, she received her M.B.A. in Marketing from The Wharton School at the University of Pennsylvania and was recently recognized by Marquis Who’s Who for her contributions in nutrition science.

12:50pm
– 1:15pm
Reformulating for Health
Why Evidence Based Claims Matter in the Next Generation of Foods​

Evolving role of food ingredients for health: Reformulation strategies that incorporate fibers, alternative sweeteners & plant proteins to improve nutritional profiles w/o compromising sensory.

Read the Abstract

As consumer interest in health and wellness accelerates, the food and beverage industry faces increasing pressure to develop ingredient solutions and reformulated products that deliver measurable physiological benefits. Health claims underscore the growing demand for offerings that support weight management, satiety, glycemic control, and overall metabolic health. Food manufacturers must balance innovation with scientific rigor, ensuring that claims about ingredient functionality and health benefits are both evidence based and compliant with global regulatory frameworks.

This talk explores the evolving role of food ingredients for health, with a focus on reformulation strategies that incorporate fibers, alternative sweeteners, and plant proteins, to improve nutritional profiles without compromising sensory quality. It highlights the importance of robust substantiation, including clinical trial and mechanistic data, to support credible claims. Special emphasis is placed on how companies can navigate ambiguous consumer desired descriptors by grounding claims in validated physiological endpoints such as satiety, glycemic response, digestive wellness, and metabolic effects.

Ultimately, the goal is to share a framework that integrates ingredient science, regulatory expectations, and consumer centric product design to enable responsible, evidence based health claims in an era defined by rapid innovation and heightened demand for reformulated, health forward foods.

Presented by

Kirstie Canene Adams, Ph.D. Director – Ingredion Nutrition Center, Scientific & Regulatory Affairs Ingredion
Bio

Dr. Kirstie Canene-Adams is the Director of Ingredion’s Nutrition Center in Global Scientific and Regulatory Affairs. She translates clinical and pre-clinical nutrition research into regulatory-compliant, business-relevant claims, and innovations. Dr. Canene-Adams regularly works with cross discipline teams in R & D, governmental affairs, Legal, Toxicology, and Marketing. She advocates for science and evidence-based regulations with trade organizations and professional scientific organizations. Previously, she held positions at Mars, Tate & Lyle, and the Kraft Foods Company.

Prior to joining the food industry, she was an Assistant Professor in the Nutrition and Foods Program at Texas State University and a Post-Doctoral Research Fellow in Pathology at Johns Hopkins University School of Medicine where her research focus was on tomatoes and broccoli for chemoprevention. Dr. Canene-Adams received her PhD in Nutritional Sciences and BS in Food Science and Human Nutrition from the University of Illinois at Urbana-Champaign.

1:15pm
– 2:00pm
Panel Discussion and Q&A
What’s the best focus for healthier dietary choices. How can we make a tangible health differences for consumers?

Current Processed Foods Landscape. Dietary Scrutiny & Regulatory Pressures​.

Weight Management – How to Transition food offerings for tasty, healthier choices.

Presented by

Martin Slayne Vice President : Scientific & Regulatory Affairs Ingredion
Bio

Martin Slayne, PhD, is Vice President, Global Scientific & Regulatory Affairs, Innovation at Ingredion Incorporated. Prior roles heading global scientific and regulatory affairs, food safety and nutrition organizations at The Hershey Company, Mondelez International and PepsiCo.  Leading global government engagement programs and cross-sector collaboration, including past roles as Regulator on food chemical safety and feed legislation at the European Commission in Brussels, and UK Food Standards Agency in London. Extensive experience with global food standards and food policy, including Codex Alimentarius. A scientific background, with PhD and Masters, medical microbiology. Advocate for credible science, evidence-based decision-making, and rational food and health policies that tangibly benefit people. Collaborate and build consumer trust. A strong advocate for community environmental sustainability.

2:00pm
Wrap-Up & Thank You

Panel Discussion Closing thoughts – Martin Slayne

Thank You & Wrap Up – Margaux Mora

Presented by

Margaux Mora​

Back to Suppliers’ Day 2026

Schedule

9:00 AM – 2:00 PM – Technical Seminars
10:30 AM – 10:45 AM – Mid-Morning Break
11:55 AM – 12:30 PM – Lunch

Fee

Attendance – $25

The $25 fee for attending the Technical Seminars includes breakfast, lunch, and learning! Visiting with exhibitors in the Exhibit Hall is complimentary.

Location

Birchwood Manor